Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-cell replacement for type I diabetes.

Peter G Stock1, Jeffrey A Bluestone

  • 1Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, California 94143, USA. stockp@surgery.ucsf.edu

Annual Review of Medicine
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Implementation of Organ Donation Following Medical Assistance in Dying: Recommendations of the Ethics Committee of the Transplantation Society.

Transplantation·2026
Same author

OPTN/SRTR 2024 Annual Data Report: Pancreas.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Pharmacology and nonclinical development of teplizumab, a first-in-class immunotherapy for delaying the onset of type 1 diabetes.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Comparison of Laparoscopic and Hand-assisted Live Donor Nephrectomy: An Analysis of NSQIP Transplant.

Transplantation direct·2026
Same author

Determinants of early readmission following liver transplantation: A National analysis of the TransQIP database.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Antiobesity Interventions in Living Organ Donor Candidates: Ethical and Policy Considerations.

Transplantation·2026

Pancreatic islet transplantation offers a safer alternative to whole pancreas transplants for diabetes, potentially preventing complications. Advances in isolation and immunosuppression are renewing interest in this beta-cell replacement therapy.

Area of Science:

  • Endocrinology
  • Transplantation immunology
  • Regenerative medicine

Background:

  • Solid-organ pancreas transplantation can achieve insulin independence but is often pursued too late to prevent irreversible diabetes complications.
  • Pancreatic islet transplantation presents a less invasive, safer alternative for beta-cell replacement therapy.
  • Early intervention with islet transplantation could prevent secondary complications of diabetes.

Purpose of the Study:

  • To review advances in pancreatic islet transplantation as a beta-cell replacement strategy.
  • To highlight the potential of islet transplantation to prevent diabetes complications.
  • To identify key areas for future development in islet transplantation.

Main Methods:

  • Review of recent technological advancements in islet isolation techniques.

Related Experiment Videos

  • Analysis of immunosuppressive strategies to prevent alloimmune and autoimmune responses.
  • Discussion of challenges and future directions in the field.

    • Main Results:

    • Improved islet isolation technologies enhance transplantation feasibility.
    • Development of non-beta-cell-toxic immunosuppressive regimens is crucial.
    • Successful islet transplantation can lead to insulin independence and prevent diabetes sequelae.

    Conclusions:

    • Pancreatic islet transplantation is a promising, safer alternative for managing type 1 diabetes.
    • Further advancements in selective immunosuppression, immunologic tolerance, and beta-cell sourcing are necessary for widespread application.
    • Islet transplantation holds potential for earlier intervention to halt diabetes progression.